Published in Psychopharmacol Bull on January 01, 1994
Demographic characteristics, phenomenology, comorbidity, and family history in 200 individuals with body dysmorphic disorder. Psychosomatics (2005) 2.13
Axis I comorbidity in body dysmorphic disorder. Compr Psychiatry (2003) 1.73
Insight in obsessive compulsive disorder and body dysmorphic disorder. Compr Psychiatry (2003) 1.44
Delusional versus nondelusional body dysmorphic disorder: clinical features and course of illness. J Psychiatr Res (2005) 1.38
Suicidality in body dysmorphic disorder: a prospective study. Am J Psychiatry (2006) 1.33
A 12-month follow-up study of the course of body dysmorphic disorder. Am J Psychiatry (2006) 1.14
Treating body dysmorphic disorder with medication: evidence, misconceptions, and a suggested approach. Body Image (2008) 1.11
Body dysmorphic disorder: some key issues for DSM-V. Depress Anxiety (2010) 1.07
Body dysmorphic disorder. Postgrad Med J (2004) 1.04
Features of men with anabolic-androgenic steroid dependence: A comparison with nondependent AAS users and with AAS nonusers. Drug Alcohol Depend (2009) 1.04
Depression, anxiety, anger, and somatic symptoms in patients with body dysmorphic disorder. Psychiatr Q (2004) 1.00
Olfactory reference syndrome: issues for DSM-V. Depress Anxiety (2010) 0.97
Body dysmorphic disorder: recognizing and treating imagined ugliness. World Psychiatry (2004) 0.91
A retrospective follow-up study of body dysmorphic disorder. Compr Psychiatry (2005) 0.90
Relationship between social anxiety disorder and body dysmorphic disorder. Clin Psychol Rev (2010) 0.90
The obsessive-compulsive spectrums. Psychiatr Clin North Am (2002) 0.88
Pharmacotherapy for body dysmorphic disorder: treatment received and illness severity. Ann Clin Psychiatry (2006) 0.88
Predictors of remission from body dysmorphic disorder: a prospective study. J Nerv Ment Dis (2005) 0.87
Modular cognitive-behavioral therapy for body dysmorphic disorder: a randomized controlled trial. Behav Ther (2013) 0.86
Prevalence and clinical characteristics of body dysmorphic disorder in an adult inpatient setting. Gen Hosp Psychiatry (2007) 0.84
A comparison of insight in body dysmorphic disorder and obsessive-compulsive disorder. J Psychiatr Res (2012) 0.82
Obsessive-compulsive spectrum of disorders: a defensible construct? Aust N Z J Psychiatry (2006) 0.82
Body dysmorphic disorder and cosmetic dermatology: more than skin deep. J Cosmet Dermatol (2004) 0.81
White matter microstructure in body dysmorphic disorder and its clinical correlates. Psychiatry Res (2013) 0.81
Recognizing and treating body dysmorphic disorder. Ann Clin Psychiatry (2006) 0.80
Different aspects of informed consent in aesthetic surgeries. World J Plast Surg (2014) 0.80
Cognitive-behavioral therapy for youth with body dysmorphic disorder: current status and future directions. Child Adolesc Psychiatr Clin N Am (2011) 0.78
Delusional versus nondelusional body dysmorphic disorder: recommendations for DSM-5. CNS Spectr (2013) 0.78
A Review of 20 Years of Research on Overdiagnosis and Underdiagnosis in the Rhode Island Methods to Improve Diagnostic Assessment and Services (MIDAS) Project. Can J Psychiatry (2016) 0.76
Body dysmorphic disorder. Dialogues Clin Neurosci (2010) 0.76
Body dysmorphic disorder: a guide for primary care physicians. Prim Care (2002) 0.76
Psychometric evaluation of the Brown Assessment of Beliefs Scale in body dysmorphic disorder. J Nerv Ment Dis (2013) 0.75
Obsessive-compulsive spectrum disorders. Dialogues Clin Neurosci (2003) 0.75
Pharmacotherapy for Body Dysmorphic Disorder. Psychiatr Ann (2010) 0.75
Cued panic attacks in body dysmorphic disorder. J Psychiatr Pract (2013) 0.75
The Structured Clinical Interview for DSM-III-R (SCID). II. Multisite test-retest reliability. Arch Gen Psychiatry (1992) 7.36
Risk of bacterial infection associated with allogeneic blood transfusion among patients undergoing hip fracture repair. Transfusion (1999) 5.67
Development and validation of a screening instrument for bipolar spectrum disorder: the Mood Disorder Questionnaire. Am J Psychiatry (2000) 5.21
Body dysmorphic disorder: 30 cases of imagined ugliness. Am J Psychiatry (1993) 4.57
Recovered memories of childhood sexual abuse. BMJ (1998) 3.36
Attitudes toward DSM-IV dissociative disorders diagnoses among board-certified American psychiatrists. Am J Psychiatry (1999) 3.29
Neuropsychological performance in long-term cannabis users. Arch Gen Psychiatry (2001) 3.27
Psychiatric features of individuals with problematic internet use. J Affect Disord (2000) 3.19
Tranylcypromine vs. lamotrigine in the treatment of refractory bipolar depression: a failed but clinically useful study. Acta Psychiatr Scand (2007) 2.89
A randomized, placebo-controlled 12-month trial of divalproex and lithium in treatment of outpatients with bipolar I disorder. Divalproex Maintenance Study Group. Arch Gen Psychiatry (2000) 2.88
Clinical and research implications of the diagnosis of dysphoric or mixed mania or hypomania. Am J Psychiatry (1992) 2.70
Fluoxetine-induced akathisia: clinical and theoretical implications. J Clin Psychiatry (1989) 2.67
Affective spectrum disorder: does antidepressant response identify a family of disorders with a common pathophysiology? Am J Psychiatry (1990) 2.64
Standards for informed consent in recovered memory therapy. J Am Acad Psychiatry Law (2001) 2.60
The Stanley Foundation Bipolar Treatment Outcome Network. II. Demographics and illness characteristics of the first 261 patients. J Affect Disord (2001) 2.43
Axis I psychiatric comorbidity and its relationship to historical illness variables in 288 patients with bipolar disorder. Am J Psychiatry (2001) 2.38
Efficacy of olanzapine in acute bipolar mania: a double-blind, placebo-controlled study. The Olanzipine HGGW Study Group. Arch Gen Psychiatry (2000) 2.34
Compulsive buying: a report of 20 cases. J Clin Psychiatry (1994) 2.29
Time course of antipsychotic effects of neuroleptic drugs. Am J Psychiatry (1989) 2.07
Risk factors for neuroleptic malignant syndrome. A case-control study. Arch Gen Psychiatry (1989) 1.94
12-month outcome of patients with bipolar disorder following hospitalization for a manic or mixed episode. Am J Psychiatry (1998) 1.91
Pharmacological treatment of kleptomania and bulimia nervosa. J Clin Psychopharmacol (1989) 1.91
Characteristics of 34 adults with psychogenic excoriation. J Clin Psychiatry (1998) 1.86
Effects of supraphysiologic doses of testosterone on mood and aggression in normal men: a randomized controlled trial. Arch Gen Psychiatry (2000) 1.81
Psychogenic excoriation. Clinical features, proposed diagnostic criteria, epidemiology and approaches to treatment. CNS Drugs (2001) 1.74
Diagnosis in schizophrenia and manic-depressive illness: a reassessment of the specificity of 'schizophrenic' symptoms in the light of current research. Arch Gen Psychiatry (1978) 1.72
CSF norepinephrine concentrations in posttraumatic stress disorder. Am J Psychiatry (2001) 1.71
MDMA ("Ecstasy") abuse and high-risk sexual behaviors among 169 gay and bisexual men. Am J Psychiatry (2000) 1.66
Body image in boys: a review of the literature. Int J Eat Disord (2001) 1.63
Enhanced response to repeated d-amphetamine challenge: evidence for behavioral sensitization in humans. Biol Psychiatry (1996) 1.62
Rapid remission of OCD with tramadol hydrochloride. Am J Psychiatry (1999) 1.61
Abstinence symptoms during withdrawal from chronic marijuana use. Exp Clin Psychopharmacol (2000) 1.61
Muscle dysmorphia: a new syndrome in weightlifters. Br J Sports Med (2002) 1.60
Comorbidity of fibromyalgia with medical and psychiatric disorders. Am J Med (1992) 1.58
The efficacy of lamotrigine in rapid cycling and non-rapid cycling patients with bipolar disorder. Biol Psychiatry (1999) 1.58
Mood switch in bipolar depression: comparison of adjunctive venlafaxine, bupropion and sertraline. Br J Psychiatry (2006) 1.58
Minimizing and managing antidepressant side effects. J Clin Psychiatry (1995) 1.57
Residual catatonic state following neuroleptic malignant syndrome. J Clin Psychopharmacol (2000) 1.55
Obsessive compulsive spectrum disorder. J Clin Psychiatry (1994) 1.54
Antidepressant activity and mania associated with risperidone treatment of schizoaffective disorder. Lancet (1994) 1.52
Is childhood sexual abuse a risk factor for bulimia nervosa? Am J Psychiatry (1992) 1.51
Frequency and presentation of neuroleptic malignant syndrome in a large psychiatric hospital. Am J Psychiatry (1986) 1.47
Prevalence and severity of akathisia in patients on clozapine. Biol Psychiatry (1991) 1.47
Mania, psychosis, and antipsychotics. J Clin Psychiatry (1996) 1.47
Antidepressant treatment of fibromyalgia. A meta-analysis and review. Psychosomatics (2000) 1.45
Valproate in the treatment of rapid-cycling bipolar disorder. J Clin Psychopharmacol (1988) 1.44
An overview of the treatment of schizoaffective disorder. J Clin Psychiatry (1999) 1.44
Are impulse-control disorders related to bipolar disorder? Compr Psychiatry (1996) 1.42
Canadian and American psychiatrists' attitudes toward dissociative disorders diagnoses. Can J Psychiatry (2001) 1.42
Efficacy and safety of fluvoxamine in body dysmorphic disorder. J Clin Psychiatry (1998) 1.40
Olanzapine versus placebo in the treatment of acute mania. Olanzapine HGEH Study Group. Am J Psychiatry (1999) 1.40
Autoinduction of hypertensive reactions by tranylcypromine? J Clin Psychopharmacol (1989) 1.39
A new identity for misidentification syndromes. Compr Psychiatry (1994) 1.39
A pilot study of rapid lithium administration in the treatment of acute mania. Bipolar Disord (2001) 1.39
A comparison study of body dysmorphic disorder and obsessive-compulsive disorder. J Clin Psychiatry (1998) 1.31
A double-blind, placebo-controlled, prophylaxis study of lamotrigine in rapid-cycling bipolar disorder. Lamictal 614 Study Group. J Clin Psychiatry (2000) 1.28
Muscle dysmorphia in male weightlifters: a case-control study. Am J Psychiatry (2000) 1.27
Composite International Diagnostic Interview screening scales for DSM-IV anxiety and mood disorders. Psychol Med (2012) 1.26
Body image perception among men in three countries. Am J Psychiatry (2000) 1.24
Validation of the prospective NIMH-Life-Chart Method (NIMH-LCM-p) for longitudinal assessment of bipolar illness. Psychol Med (2000) 1.24
Somatic treatment of catatonia. Int J Psychiatry Med (1995) 1.22
Cultural expectations of muscularity in men: the evolution of playgirl centerfolds. Int J Eat Disord (2001) 1.21
Psychiatric and medical effects of anabolic-androgenic steroid use in women. Psychother Psychosom (2000) 1.20
Twelve-month outcome after a first hospitalization for affective psychosis. Arch Gen Psychiatry (1998) 1.20
Increased aggressive responding in male volunteers following the administration of gradually increasing doses of testosterone cypionate. Drug Alcohol Depend (1995) 1.19
Valproate in the treatment of acute mania. A placebo-controlled study. Arch Gen Psychiatry (1991) 1.18
Personality disorders and traits in patients with body dysmorphic disorder. Compr Psychiatry (2000) 1.18
Questionable validity of 'dissociative amnesia' in trauma victims. Evidence from prospective studies. Br J Psychiatry (1998) 1.18
Placebo effect in randomized, controlled studies of acute bipolar mania and depression. Biol Psychiatry (2000) 1.18